Iovance Biotherapeutics, Inc. (IOVA)
2.27
-0.04
(-1.73%)
USD |
NASDAQ |
Dec 09, 14:50
Iovance Biotherapeutics EPS Diluted (Quarterly): -0.2507 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Plus Therapeutics, Inc. | -0.0412 |
| Talphera, Inc. | -0.107 |
| Lantheus Holdings, Inc. | 0.4104 |
| iRhythm Technologies, Inc. | -0.162 |
| Day One Biopharmaceuticals, Inc. | -0.1908 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -91.25M |
| Revenue (Quarterly) | 67.46M |
| Total Expenses (Quarterly) | 158.71M |
| Enterprise Value | 668.69M |
| Gross Profit Margin (Quarterly) | 29.61% |
| Profit Margin (Quarterly) | -135.3% |
| Earnings Yield | -52.95% |
| Normalized Earnings Yield | -52.52 |